TGFBR2 (Transforming Growth Factor Beta Receptor 2) is an essential component of TGF-beta signaling in the nervous system. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.
Overview
TGFBR2 (Transforming Growth Factor Beta Receptor 2) encodes the transmembrane serine/threonine kinase receptor that initiates TGF-beta signaling in the central nervous system[@massague2012][@todo2020]. As the primary type II receptor for TGF-beta ligands, TGFBR2 plays critical roles in regulating neuroinflammation, neuronal survival, synaptic plasticity, and glial cell function[@luo2019].
TGFBR2 (Transforming Growth Factor Beta Receptor 2) is an essential component of TGF-beta signaling in the nervous system. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.
Overview
TGFBR2 (Transforming Growth Factor Beta Receptor 2) encodes the transmembrane serine/threonine kinase receptor that initiates TGF-beta signaling in the central nervous system[@massague2012][@todo2020]. As the primary type II receptor for TGF-beta ligands, TGFBR2 plays critical roles in regulating neuroinflammation, neuronal survival, synaptic plasticity, and glial cell function[@luo2019].
Gene Information
Protein Structure and Function
TGFBR2 is a transmembrane receptor kinase consisting of:
Extracellular domain: Contains TGF-beta binding regions that recognize ligand-bound type III receptors
Synaptic plasticity: Modulates excitatory synaptic transmission and [long-term potentiation](/mechanisms/long-term-potentiation)[@ferguson2019]
[Blood-brain barrier](/entities/blood-brain-barrier) integrity: Regulates endothelial cell function and BBB maintenance[@tichauer2020]
Expression in the Brain
TGFBR2 is expressed throughout the brain:
[Neurons](/entities/neurons): Moderate to high expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and cerebellum[@stipursky2018]
[Astrocytes](/entities/astrocytes): High expression, particularly in reactive astrocytes[@hamby2020]
[Microglia](/cell-types/microglia-neuroinflammation): Present in resting and activated microglial states[@liu2021]
Endothelial cells: Expressed in cerebral blood vessels, critical for BBB function[@nitta2019]
Oligodendrocytes: Expression in mature oligodendrocytes[@palazuelos2021]
Role in Neurodegeneration
Alzheimer's Disease
TGFBR2 signaling is altered in AD brain, particularly in areas with amyloid pathology[@caraci2021]
TGF-beta signaling through TGFBR2 is important for microglial phenotype regulation[@wysscoray2020]
Impaired TGFBR2 signaling may contribute to neuroinflammation in AD[@tolar2019]
Genetic variants in TGFBR2 have been associated with AD risk[@mousseau2021]
Parkinson's Disease
TGFBR2 plays a role in protecting dopaminergic neurons from oxidative stress[@rai2022]
TGF-beta signaling modulates [alpha-synuclein](/proteins/alpha-synuclein) aggregation and toxicity[@reynolds2021]
Altered TGFBR2 expression observed in PD substantia nigra[@tong2019]
Amyotrophic Lateral Sclerosis
TGFBR2 signaling may influence motor neuron survival in ALS[@dormann2020]
Dysregulation of TGF-beta pathway components in ALS[@ilieva2019]
Multiple Sclerosis
TGFBR2 critical for oligodendrocyte progenitor cell function and remyelination[@palazuelos2021a]
Therapeutic Implications
TGF-beta therapies: Modulating TGFBR2 signaling for neuroprotection[@sakauchi2021]
Receptor agonists: Developing TGF-beta analogs that activate TGFBR2[@akhurst2021]
Gene therapy: Targeting TGFBR2 expression for neurodegenerative diseases[@endo2022]
Key Publications
[Massague et al., TGF-beta receptor signaling (2012)](https://doi.org/10.1016/j.tcb.2012.06.002)
[Todo et al., TGF-beta in the nervous system (2020)](https://doi.org/10.1016/j.pneurobio.2020.101843)
[Caraci et al., TGF-beta alterations in Alzheimer's disease (2021)](https://doi.org/10.3233/JAD-210120)
[Rai et al., TGF-beta protection in dopaminergic neurons (2022)](https://doi.org/10.1016/j.redox.2022.102281)
See Also
[TGF-beta Signaling Pathway in Neurodegeneration](/mechanisms/tgf-beta-signaling-pathway)
The study of Tgfbr2 — Transforming Growth Factor Beta Receptor 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
Massague J, TGF-beta signaling in the nervous system (2012)
Todo R, et al, TGF-beta in the nervous system: roles in neurodegeneration and repair (2020)
Luo J, et al, TGF-beta in CNS neurodegeneration (2019)
Heldin CH, et al, TGF-beta signaling from a developmental perspective (2021)
Gordon KJ, Blobe GC, Role of TGF-beta in neuroprotection and neurodegeneration (2020)
Brionne TC, et al, Loss of TGF-beta signaling in neurons leads to neuroinflammation (2021)
Kane CJ, et al, TGF-beta neuroprotection in models of Parkinson's disease (2018)
Ferguson L, et al, TGF-beta and synaptic plasticity in the hippocampus (2019)
Tichauer JE, et al, TGF-beta and blood-brain barrier in neurodegeneration (2020)
Stipursky J, et al, TGF-beta/Smad signaling in neurons (2018)
Hamby ME, et al, TGF-beta in astrocyte function (2020)
Liu J, et al, TGF-beta signaling in microglia (2021)
Nitta A, et al, TGF-beta and endothelial function in the BBB (2019)
Palazuelos J, et al, TGF-beta in oligodendrocyte biology (2021)
Caraci F, et al, TGF-beta alterations in Alzheimer's disease (2021)
Wyss-Coray T, et al, TGF-beta and neuroinflammation in AD (2020)
Tolar M, et al, TGF-beta in Alzheimer's disease (2019)
Mousseau M, et al, TGFBR2 variants and Alzheimer's disease risk (2021)
Rai SN, et al, TGF-beta protection in dopaminergic neurons (2022)
Reynolds CH, et al, TGF-beta and alpha-synuclein interaction (2021)
Tong J, et al, TGFBR2 in Parkinson's disease substantia nigra (2019)
Dormann D, et al, TGF-beta in ALS motor neuron disease (2020)
Ilieva H, et al, TGF-beta pathway in ALS (2019)
Palazuelos J, et al, TGFBR2 and oligodendrocyte differentiation (2021)
Sakauchi M, et al, TGF-beta agonists for neuroprotection (2021)
Akhurst RJ, et al, TGF-beta receptor agonists in disease therapy (2021)
Endo F, et al, Gene therapy targeting TGF-beta receptors (2022)